A functional role of CSF-1R in melanoma spread was also demonstrated by Giricz et al., showing a dose-dependent decrease in melanoma invasiveness after treatment with the CSF-1R inhibitor PLX3397 [13]. The gene discussed is CSF1R; the disease is melanoma.